Anti-CD20 mAbs were originally created to treat B cell proliferative diseases such as non-Hodgkin's lymphoma and chronic ...
The addition of epcoritamab-bysp to standard chemotherapy significantly improved response and survival for patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback